Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
304
-
Total 13F shares, excl. options
-
50.5M
-
Shares change
-
+257K
-
Total reported value, excl. options
-
$7.42B
-
Value change
-
+$48.4M
-
Put/Call ratio
-
1.19
-
Number of buys
-
155
-
Number of sells
-
-157
-
Price
-
$147.01
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2014
381 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2014.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 304 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.5M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (7.65M shares), FMR LLC (5.94M shares), JANUS CAPITAL MANAGEMENT LLC (3.32M shares), VANGUARD GROUP INC (3.1M shares), WELLS FARGO & COMPANY/MN (2.09M shares), LONE PINE CAPITAL LLC (2.09M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.89M shares), Westpac Banking Corp (1.54M shares), BlackRock Institutional Trust Company, N.A. (1.35M shares), and BlackRock Fund Advisors (1.26M shares).
This table shows the top 304 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.